Intravenous Iron Dextran as a Component of Anemia Management in Chronic Kidney Disease: A Report of Safety and Efficacy

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Product name</td><td align="center">ASP per gram</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Iron dextran (Infed)</td><td align="center">$240.0</td></tr><tr><td align="left">Iron dextran (Dexferrum)</td><td align="center">$240.0</td></tr><tr><td align="left">Iron sucrose (Venofer)</td><td align="center">$285.0</td></tr><tr><td align="left">Sodium ferric gluconate (Ferrlecit)</td><td align="center">$265.2</td></tr><tr><td align="left">Ferumoxytol (Feraheme)</td><td align="center">$638.0</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Average selling price (ASP) based on Centers for Medicaid and Medicare Services.

International Journal of Nephrology

tab4

Table 4

Table 4: Intravenous Iron Dextran as a Component of Anemia Management in Chronic Kidney Disease: A Report of Safety and Efficacy 